Not Just Growth: Why Stability Sells Better in Healthcare M&A
Not Just Growth: Why Stability Sells Better in Healthcare M&A Key Takeaways The Big Misconception: Why Growth Alone Doesn’t Win Deals Why High-Revenue Practices Still Fail to Attract Buyers Many healthcare owners assume rising revenue guarantees buyer interest. In reality, investors working with healthcare M&A advisors look beyond top-line growth, focusing on consistency, margins, and […]
Read More
The Wrong Buyer Problem: Why More Outreach Does Not Always Mean Better Deals
The Wrong Buyer Problem: Why More Outreach Does Not Always Mean Better Deals Key Takeaways Why Quantity Outreach Fails In healthcare M&A, sending mass outreach may seem productive, but it often backfires. Buyers skim opportunities quickly, filtering out any that don’t immediately align with their strategic goals. Rather than chasing volume, sellers and CEOs benefit […]
Read More
Healthcare CEO Guide: What Your Board or Partners Must Decide Before LOI
Healthcare CEO Guide: What Your Board or Partners Must Decide Before LOI Key Takeaways Why Alignment Must Happen Before LOI An LOI should confirm a shared strategy, not expose internal conflict. In 2025, 47% of directors said M&A was a strategic priority for their boards, showing how early governance matters in real transactions. Buyers also […]
Read More
How to Sell With Slowing Growth: Defending Your Healthcare Company Multiple
How to Sell With Slowing Growth: Defending Your Healthcare Company Multiple Key Takeaways Why Slowing Growth Does Not Kill Value A slowdown in growth can make owners nervous, but it does not automatically mean buyers will slash valuation. In healthcare M&A, quality still matters more than panic. If your margins, retention, and operations remain solid, […]
Read More
Healthcare CEO Guide: Choosing Between a Broad Process vs Targeted Outreach
Healthcare CEO Guide: Choosing Between a Broad Process vs Targeted Outreach Key Takeaways Broad vs Targeted Choosing between a broad process and targeted outreach is really a choice between reach and control. A wider process can surface more buyers, while a narrower one can protect confidentiality and focus attention. That balance also appears in The […]
Read More
Healthcare CEO Guide: Pricing Strategy—When to Push, When to Protect Certainty
Healthcare CEO Guide: Pricing Strategy—When to Push, When to Protect Certainty Key Takeaways The Real CEO Dilemma: Maximize Valuation or Maximize Certainty? Every healthcare CEO eventually faces the same uncomfortable question: Should I push for the highest valuation possible—or protect certainty and close cleanly? In previous cycles, the answer seemed obvious. Capital was cheap. Private […]
Read More
The Healthcare CEO’s Guide to Setting a Realistic Valuation Range Without Underselling
The Healthcare CEO’s Guide to Setting a Realistic Valuation Range Without Underselling Key Takeaways Why Accurate Healthcare Practice Valuation Matters for CEOs As a healthcare CEO, determining the right value for your practice is more than just a number on a balance sheet—it’s the foundation for your financial future. Overpricing may scare away serious buyers, […]
Read More
Capital Stack Decisions That Determine Control After the Deal
Capital Stack Decisions That Determine Control After the Deal Key Takeaways Why Capital Stack Decisions Matter More Than Valuation After the Deal For many healthcare founders, the headline valuation dominates deal discussions. Yet, months after closing, a painful realization often sets in: control has quietly shifted. Strategic decisions now require approvals, board seats feel symbolic, […]
Read More
Designing Exit Optionality Before You Ever Sell a Majority Stake
Designing Exit Optionality Before You Ever Sell a Majority Stake Key Takeaways Understanding Exit Optionality and Why It Matters Why Exit Optionality Matters Long Before a Majority Sale Many healthcare founders believe exit planning begins when they are “ready to sell.” In reality, the most successful exits are engineered long before a buyer is ever […]
Read More